{"address1": "125 Strafford Avenue", "address2": "Suite 360", "city": "Wayne", "state": "PA", "zip": "19087", "country": "United States", "phone": "484 253 1461", "website": "https://palvellatx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases. Its lead product candidate is QTORIN 3.9% rapamycin anhydrous gel (QTORIN rapamycin) that is in Phase 3 clinical trial for the treatment of microcystic lymphatic malformations, as well as in Phase 2 clinical trial to treat cutaneous venous malformations. It also develops QTORIN rapamycin for the treatment of other mTOR-driven skin diseases. The company is based in Wayne, Pennsylvania.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Wesley H. Kaupinen", "title": "Founder, President, CEO & Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matthew E. Korenberg", "age": 49, "title": "CFO & Treasurer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kathleen  Goin", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Braham  Shroot Ph.D.", "age": 81, "title": "Chief Technical Officer", "yearBorn": 1943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey  Martini Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1978, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bohan  Wei", "title": "Vice President of Corporate Development & New Product Planning", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Emily  Cook", "title": "Senior Vice President of Clinical Operations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  Burdette", "title": "SVP of CMC & Technical Operations", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 27.99, "open": 28.3, "dayLow": 23.42, "dayHigh": 28.71, "regularMarketPreviousClose": 27.99, "regularMarketOpen": 28.3, "regularMarketDayLow": 23.42, "regularMarketDayHigh": 28.71, "payoutRatio": 0.0, "trailingPE": 11.974619, "volume": 93689, "regularMarketVolume": 93689, "averageVolume": 63086, "averageVolume10days": 108630, "averageDailyVolume10Day": 108630, "bid": 23.21, "ask": 24.15, "bidSize": 1, "askSize": 1, "marketCap": 264710464, "fiftyTwoWeekLow": 6.2, "fiftyTwoWeekHigh": 29.27, "fiftyDayAverage": 20.6217, "twoHundredDayAverage": 16.1124, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 240568048, "forwardPE": -4.069578, "profitMargins": 0.0, "floatShares": 3312000, "sharesOutstanding": 11221300, "sharesShort": 39362, "sharesShortPriorMonth": 27175, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0034999999, "heldPercentInsiders": 0.17499, "heldPercentInstitutions": 0.37208998, "shortRatio": 0.71, "impliedSharesOutstanding": 11221300, "bookValue": -15.28, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -7751000, "trailingEps": 1.97, "lastSplitFactor": "1:80", "lastSplitDate": 1713830400, "52WeekChange": 0.6946839, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 23.59, "targetHighPrice": 70.0, "targetLowPrice": 38.0, "targetMeanPrice": 49.25, "targetMedianPrice": 47.0, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 14207000, "totalCashPerShare": 2.484, "totalDebt": 24069000, "quickRatio": 1.861, "currentRatio": 2.138, "operatingCashflow": -7874000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PVLA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Palvella Therapeutics, Inc.", "shortName": "Palvella Therapeutics, Inc.", "regularMarketChangePercent": -15.719898, "regularMarketPrice": 23.59, "marketState": "PRE", "preMarketPrice": 24.69, "regularMarketChange": -4.3999996, "regularMarketDayRange": "23.42 - 28.71", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 63086, "fiftyTwoWeekLowChange": 17.39, "fiftyTwoWeekLowChangePercent": 2.8048387, "fiftyTwoWeekRange": "6.2 - 29.27", "fiftyTwoWeekHighChange": -5.6800003, "fiftyTwoWeekHighChangePercent": -0.19405535, "fiftyTwoWeekChangePercent": 69.46839, "earningsTimestamp": 1743420600, "earningsTimestampStart": 1747166400, "earningsTimestampEnd": 1747684800, "earningsCallTimestampStart": 1743424200, "earningsCallTimestampEnd": 1743424200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1.97, "epsCurrentYear": -6.09167, "priceEpsCurrentYear": -3.8725014, "fiftyDayAverageChange": 2.9682999, "fiftyDayAverageChangePercent": 0.1439406, "twoHundredDayAverageChange": 7.4776, "twoHundredDayAverageChangePercent": 0.46408978, "priceToBook": -1.5438482, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1420209000000, "preMarketChange": 1.1000004, "preMarketChangePercent": 4.6629944, "corporateActions": [], "preMarketTime": 1743583686, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_534271315", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Palvella Therapeutics", "trailingPegRatio": null}